Covid's 'Silver Lining': Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Researchers see promise in mRNA to treat cancer, cystic fibrosis, and rare, inherited metabolic disorders.
Stay updated with breaking news from Recode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers see promise in mRNA to treat cancer, cystic fibrosis, and rare, inherited metabolic disorders.
The massive investments into COVID-19 research are expected to yield medical and scientific dividends for decades, helping doctors battle influenza, cancer, cystic fibrosis and other diseases. The research already has led to new insights on how respiratory viruses spread and a paradigm shift in immunology.
Billions of dollars invested in mRNA vaccines and COVID research could yield health care dividends for decades to come.
The billions of dollars invested in COVID vaccines and COVID-19 research so far are expected to yield medical and scientific dividends for decades, helping doctors battle influenza, cancer, cystic fibrosis, and far more diseases.
Billions of dollars invested in mRNA vaccines and COVID research could yield healthcare dividends for decades to come.